Uni Eropa - Sloven - EMA (European Medicines Agency)

sanofi b.v. - tirotropin alfa - Širokopasemske neoplazme - spodnjega režnja hipofize hormoni in analogi, hipofize in hypothalamic hormoni in analogi - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Uni Eropa - Sloven - EMA (European Medicines Agency)

zambon spa - safinamid metansulfonat - parkinsonova bolezen - anti-parkinsonska zdravila - xadago je indicirano za zdravljenje odraslih bolnikov z idiopatsko parkinsonovo boleznijo (pb) kot dodatek zdravljenja stabilne odmerek levodopo (l-dopa), samostojno ali v kombinaciji z drugimi pd zdravili v sredi-pozni fazi nihajoče bolnikom.

Uni Eropa - Sloven - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostatične neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Uni Eropa - Sloven - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - novorapid je indiciran za zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 1 leto in več.

Uni Eropa - Sloven - EMA (European Medicines Agency)

csl behring gmbh - humani normalni imunoglobulin (ivig) - purpura, thrombocytopenic, idiopathic; bone marrow transplantation; immunologic deficiency syndromes; guillain-barre syndrome; mucocutaneous lymph node syndrome - imunski sera in imunoglobulini, - nadomestno zdravljenje pri odraslih in otrok in mladostnikov (0-18 let) v:primarne imunske pomanjkljivosti (pid) sindromov s slabšo proizvodnjo protiteles;hypogammaglobulinaemia in ponavljajoče se bakterijske okužbe pri bolnikih s kronično limfocitno levkemijo, pri katerih profilaktičnih antibiotikov ni uspelo;hypogammaglobulinaemia in ponavljajoče se bakterijske okužbe v planota-faza-več-plazmocitom bolnikih, ki so se odzvali na pnevmokokna imunizacijo;hypogammaglobulinaemia pri bolnikih po allogeneic haematopoietic-matičnih-celic presaditev (hsct);prirojene pomoČi z ponavljajoče se bakterijske okužbe. immunomodulation pri odraslih in otrok in mladostnikov (0-18 let) v:primarna imunska trombocitopenija (itp), pri bolnikih z visokim tveganjem za krvavitve ali pred operacijo, da se popravi trombocitov štetje;guillain-barré sindrom;kawasaki bolezni, kronične vnetne demielinizirajoče polyneuropathy (cidp). le omejene izkušnje je na voljo za uporabo intravenskih imunoglobulini pri otrocih s cidp.

Uni Eropa - Sloven - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - sladkorna bolezen - drugs used in diabetes, insulins and analogues for injection, fast-acting - zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 1 leto in več.

Uni Eropa - Sloven - EMA (European Medicines Agency)

instituto grifols s.a. - Človekove normalno imunoglobulina - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - imunski sera in imunoglobulini, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Uni Eropa - Sloven - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetes mellitus.

Uni Eropa - Sloven - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart, insulin degludec - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 2 leti.

Uni Eropa - Sloven - EMA (European Medicines Agency)

molmed spa - alogenskih t celice, gensko spremenjene z retrovirusni vektor kodiranje za skrajšani obliki ljudi nizko afiniteto živca rastni faktor receptor (Δlngfr) in herpes simplex virus timidin-kinazo (hsv-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastična sredstva - zalmoxis je indiciran kot dodatno zdravljenje pri haploidentični hematopoetski presaditvi matičnih celic (hsct) pri odraslih bolnikih z visokim tveganjem hematoloških malignomov.